Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells.
about
Systemic chemotherapy induces microsatellite instability in the peripheral blood mononuclear cells of breast cancer patients.Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevanceMinimal residual disease and circulating tumor cells in breast cancerCirculating tumor cells in oral squamous cell carcinoma-an enigma or reality?Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencingUse of automated microscopy for the detection of disseminated tumor cells in bone marrow samples.Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques.Cytokeratin-positive cells in the bone marrow of breast cancer patients and noncancer donorsPrognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients.Prognostic value of hematogenous dissemination and biological profile of the tumor in early breast cancer patients: a prospective observational study.Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cellsDetection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies.LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival.Cytokeratins and other sensitive markers for esophageal cancer and metastases.Microsieve lab-chip device for rapid enumeration and fluorescence in situ hybridization of circulating tumor cells.Characterization of disseminated tumor cells.Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patientsDisseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention studyDisseminated tumour cells as a prognostic biomarker in colorectal cancerPositive HER-2 protein expression in circulating prostate cells and micro-metastasis, resistant to androgen blockage but not diethylstilbestrolThe prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patientsPresence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer.The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy.Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trialDetection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study.Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapyHER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancerReal-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer.Circulating Prostate Cells Found in Men with Benign Prostate Disease Are P504S Negative: Clinical Implications.The potential for liquid biopsies in the precision medical treatment of breast cancer.Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survivalBone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues.Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevanceERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients.Clinical significance of disseminated tumour cells in non-small cell lung cancerAnalysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer. Do stem cell like cells predict prognosis?Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.
P2860
Q24796574-3E01ED0F-A3EB-410B-99DC-872F38B3B63AQ24806218-62BD02CB-6FB6-491B-B3F1-1ACD1946F0DAQ27010152-8E028CFF-628C-4546-A00D-F6588337E7BBQ27022829-232CD083-BD13-47BD-BE7A-18261492FC58Q28396153-0C013B1A-21CB-4370-9961-CC2DE0B2CF3EQ30701696-827FC999-5A72-40F4-B384-4AD91F47C7DBQ33211966-91934C25-E084-4622-880A-5668D7272F6FQ33718843-D9188CA7-6AB2-45DD-AEFA-6716C60AAF1CQ33746929-2D0A8394-8826-4AC5-8A66-DA9B9E61E9E6Q33934494-09DCF1A6-3C55-49CF-9C0F-ABAFD347E383Q33959862-8B366C43-35CB-4BFD-A882-02EB1FFF79B4Q34286198-B81CC103-668E-488D-89D1-380D7F7B6901Q34360216-F328010A-EB60-4A71-A35F-84B4C8D05579Q34366103-93293008-CB39-4D79-9817-D0A68A40DE3AQ34396921-20D089AB-D25B-44CC-BC1A-A9B249DCC34DQ34465174-519DFB41-4250-491C-9EF1-377EF548E0DFQ34468675-DF471485-32BE-4C9B-A2C2-765B54C41F86Q34520174-673A6959-DCD8-4B97-8AC2-B014218127FEQ35006944-6CEDCE54-1EB4-45EE-8123-DCEEA50B5B4FQ35125721-CCDDD041-6B14-4B30-BFAF-636E03B1E823Q35558100-FD183885-5DED-46EF-8B0C-21A1147BA805Q35605856-CB1CC3BB-DDF1-437A-A0A7-123C5DD081DAQ35681975-38613699-8559-4DAA-9C38-1E5C2C916E4DQ36069885-B2AF4F4C-A7CB-4478-951B-54350D00E091Q36249373-7EE04B15-037B-40EF-B534-C49A94C4A610Q36369695-F6FB900B-5577-455B-B114-A0CC66A93FB3Q36574920-DCB0F504-10AF-4EE7-A17B-B30D6AFC1DB6Q36609893-E3063DD4-6ED7-446A-8CA1-E7FB0F1F6406Q36671430-5658634D-1A00-4301-8F36-EA5E550F5D74Q36696215-235E5057-090C-422D-B34A-ECDA885E455BQ36838281-15A62608-0EFE-43F3-9EF3-09BA3A9CAC29Q36849660-09A4561D-4D65-4497-82CF-9638BCE01731Q36924468-7137846F-5552-4F3E-B237-7DF7CBC4C522Q36930838-5658407B-350A-497E-9C3B-CC18ED0A2FA0Q36955133-3D42B8E0-3EBF-4D8D-AECC-13354DACFA64Q37019257-AAA4E656-DE1C-4E89-8B78-76B5AFCCABBCQ37038635-F78A9304-81DE-499B-B3B6-98825CB95117Q37185823-D5BF4424-5079-46AC-8A78-A7455956B101Q37295702-437E71DD-3054-48B8-AEC8-7016AB784777Q37360230-EE7FA890-8305-409F-AD9D-05B1D1320B9A
P2860
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Standardization of the immunoc ...... uation of immunostained cells.
@en
type
label
Standardization of the immunoc ...... uation of immunostained cells.
@en
prefLabel
Standardization of the immunoc ...... uation of immunostained cells.
@en
P2093
P50
P1433
P1476
Standardization of the immunoc ...... uation of immunostained cells.
@en
P2093
E F Solomayer
G Kvalheim
J P Marolleau
P304
P356
10.1080/0032472031000141283
P577
1999-01-01T00:00:00Z